Alcon Announces Results of 2024 Annual General Meeting
May 08 2024 - 4:30PM
Business Wire
- Shareholders approve dividend of CHF 0.24 per share
- Shareholders confirm F. Michael Ball as member and Chair of
the Board of Directors as well as the other members who all stood
for re-election
- Shareholders approve the 2023 Non-Financial Matters Report
in an advisory vote
- Shareholders approve the Board and Executive Committee
compensation in separate binding votes
Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care
dedicated to helping people see brilliantly, today announced the
approval of all proposed binding resolutions at its 2024 Annual
General Meeting (AGM).
A total of 326,707,870 shares with a nominal value of CHF 0.04
each, representing an aggregate nominal value of CHF 13,068,314.80,
were represented at today's AGM.
Shareholders re-elected F. Michael Ball as member and Chair of
the Board of Directors, and the other members of the Board who all
stood for re-election, namely Lynn Bleil, Raquel Bono, Arthur
Cummings, David Endicott, Thomas Glanzmann, D. Keith Grossman,
Scott Maw, Karen May, Ines P�schel and Dieter Spälti, for a term of
one year.
In addition, shareholders re-elected Thomas Glanzmann, Karen
May, Scott Maw and Ines P�schel to form the Compensation Committee
for a period of one year.
Discharge was granted to the members of the Board of Directors
and the members of the Executive Committee for the 2023 financial
year.
In two separate binding votes, shareholders approved the maximum
aggregate amount of compensation of the Board of Directors for the
next term of office ending at the 2025 Annual General Meeting, and
the Executive Committee for 2025 financial year.
Shareholders also accepted the 2023 Non-Financial Matters Report
in a non-binding, consultative vote.
Additionally, the 2023 Compensation Report was not accepted in a
consultative, non-binding vote.
Alcon shareholders approved the operating and financial review
of Alcon Inc., the annual financial statements of Alcon Inc. and
the consolidated financial statements for 2023.
Shareholders also approved that a gross dividend of CHF 0.24 per
dividend-bearing share be declared, and that, after appropriation
of the proposed dividend, the remaining amount of available
earnings be carried forward.
Pricewaterhouse Coopers SA, Geneva, was re-elected as statutory
auditors for the 2024 financial year. Hartmann Dreyer
Attorneys-at-Law was also re-elected as the independent
representative for a term of one year extending until the 2025
AGM.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning over 75 years, we offer the broadest
portfolio of products to enhance sight and improve people’s lives.
Our Surgical and Vision Care products touch the lives of people in
over 140 countries each year living with conditions like cataracts,
glaucoma, retinal diseases and refractive errors. Our more than
25,000 associates are enhancing the quality of life through
innovative products, partnerships with Eye Care Professionals and
programs that advance access to quality eye care. Learn more at
www.alcon.com.
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508534603/en/
Investor Relations Dan
Cravens Allen Trang + 41 589 112 110 (Geneva) + 1 817 615 2789
(Fort Worth) investor.relations@alcon.com
Media Relations Steven Smith
+ 41 589 112 111 (Geneva) + 1 817 615 2501 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Aug 2023 to Aug 2024